| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/2001 | US6242462 Novel decahydroisoquinoline derivatives which are selective glur5 receptor antagonists. |
| 06/05/2001 | US6242461 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
| 06/05/2001 | US6242459 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 06/05/2001 | US6242458 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/05/2001 | US6242457 Oxime derivatives |
| 06/05/2001 | US6242456 Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors |
| 06/05/2001 | US6242455 Inhibiting a matrix metalloprotease associated disease |
| 06/05/2001 | US6242454 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| 06/05/2001 | US6242453 Polycyclo heterocyclic derivatives as antiinflammatory agents |
| 06/05/2001 | US6242452 7-aminopyrido[2,3-D]pyrimidine derivatives |
| 06/05/2001 | US6242449 Treating prostatic hypertrophy, urination disorders associated with prostatic hypertrophy, male pattern alopecia, or acne |
| 06/05/2001 | US6242448 Trisubstituted-oxazole derivatives as serotonin ligands |
| 06/05/2001 | US6242447 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 06/05/2001 | US6242446 Method for treating attention deficit disorder |
| 06/05/2001 | US6242444 5-(2,3-dihydro-5-(4-methylpiperazin-1-ylsulfonyl)-7-benzofuryl )-1-methyl-3-propyl-6,7-dihydro-1h-pyrazolo(4,3-d)pyrimidin-7-one, for example; treatment of inter alia erectile dysfunction. |
| 06/05/2001 | US6242443 1,2,4-benzothiadiazine derivatives, their preparation and use |
| 06/05/2001 | US6242442 Brinzolamide and brimonidine for treating ocular conditions |
| 06/05/2001 | US6242441 Use of brinzolamide to prevent visual field loss |
| 06/05/2001 | US6242439 Azetidinone derivatives for the treatment of HCMV infections |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242436 Use of 5alpha-androstanediol or 5alpha-androstanedione to increase dihydrotestosterone levels in humans |
| 06/05/2001 | US6242435 Compositions and methods of treating abnormal cell proliferation |
| 06/05/2001 | US6242434 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders. |
| 06/05/2001 | US6242433 Geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions |
| 06/05/2001 | US6242432 Antihypertensive activity, antihypersensitive activity; treatment of cardiovascular disease |
| 06/05/2001 | US6242431 Method for treating liver dysfunction |
| 06/05/2001 | US6242429 Antiviral ara-a derivatives having resistance to metabolism by adenosinedeaminase |
| 06/05/2001 | US6242428 Nucleosides and nucleoside dimers containing an l-sugar in at least one of the nucleosides |
| 06/05/2001 | US6242424 Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6242421 Methods for preventing and treating Alzheimer's disease |
| 06/05/2001 | US6242418 Therapeutic uses of BPI protein products for human meningococcemia |
| 06/05/2001 | US6242416 Inhibition of β-amyloid binding to the p75 nerve growth factor receptor |
| 06/05/2001 | US6242415 Mediation of cytokines by melanin |
| 06/05/2001 | US6242386 Drugs formed by hydrolysis of camphor in the presence of metallorganic compounds and basic salts |
| 06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242229 Topically applying composition including clarified and stabilized culture medium from non-photosynthetic filamentous bacterium to skin, scalp, or mucous membranes; reduces or delays aging of skin |
| 06/05/2001 | US6242220 Method for purifying covalently closed circular DNA |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/05/2001 | US6242203 Tumor-specific P450 protein |
| 06/05/2001 | US6242198 Methods of treatment of eye trauma and disorders |
| 06/05/2001 | US6242196 Inhibiting proliferation of peroxisome proliferator-activated receptors-gamma response hyperproliferative cell by contacting with agonist and mitogen activated protein kinase inhibitor |
| 06/05/2001 | US6242011 Combining sulfuric acid, distilled water and ammonium sulfate, heating and pressurizing, cooling, adding stabilizer |
| 06/05/2001 | US6242008 Spherical pharmaceutical granules comprising microcrystalline cellulose and a process for their production |
| 06/05/2001 | US6242007 Reacting pyrithione or water soluble salt with polyvalent metal salt; stabilization |
| 06/05/2001 | US6242006 β-lactam granules free of organic solvents |
| 06/05/2001 | US6242005 Crushed grape extract solvent extracted with acetone and ethyl acetate |
| 06/05/2001 | US6242003 Organic compounds |
| 06/05/2001 | US6242002 Rapidly disintegrating oral dosage form of alkali-sensitive material, effervescent base of alkaline earth metal carbonate, organic edible acid and alkali metal salt of citric acid, auxiliary ingredients |
| 06/05/2001 | US6242001 Method for producing dispersible sterol and stanol compounds |
| 06/05/2001 | US6242000 Analgesic, antiinflammatory agent |
| 06/05/2001 | US6241993 Therapeutic/cosmetic compositions comprising bradykinin antagonists for treating sensitive human skin |
| 06/05/2001 | US6241969 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 06/05/2001 | US6241961 Administering to bone marrow of patient a dose of a monoclonal antibody or antibody fragment stably coupled to a cadmium-66 radioisotope; side effect reduction |
| 06/05/2001 | US6241710 Hypodermic needle with weeping tip and method of use |
| 06/05/2001 | US6241529 Affixing dosage unit comprised of a compressed tablet of a bioerodible polymeric carrier and androgenic agent, progestin, and estrogen to buccal mucosa; useful for female hormone replacement therapy, contraception, and sexual dysfunction |
| 06/05/2001 | CA2216291C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/05/2001 | CA2216163C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/05/2001 | CA2209073C Pharmacologic management of snoring |
| 06/05/2001 | CA2198852C Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 06/05/2001 | CA2146298C Cosmetic and/or dermatological composition with a hydrophilic support and vitamin c extemporaneously mixable |
| 06/05/2001 | CA2046051C 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents |
| 06/05/2001 | CA2034592C Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2325169A1 Somatostatins and method |
| 06/02/2001 | CA2327164A1 Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| 05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038561A1 Methods of use of peptide deformylase inhibitors as novel antibacterial agents |
| 05/31/2001 | WO2001038493A1 Treatment of human infertility |
| 05/31/2001 | WO2001038490A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038399A1 Method of treating surface tissue diseases |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038344A2 Modulation of signal transduction |
| 05/31/2001 | WO2001038341A1 Polynucleotide ligands as anti-viral agents |
| 05/31/2001 | WO2001038340A1 Method of preparing clarithromycin |
| 05/31/2001 | WO2001038339A1 Antimitotic compounds |
| 05/31/2001 | WO2001038338A1 Synthetic oligomannosides, preparation and uses thereof |
| 05/31/2001 | WO2001038335A1 Phosphorus-containing dendrimers as transfection agents |
| 05/31/2001 | WO2001038332A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 05/31/2001 | WO2001038331A2 Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition |
| 05/31/2001 | WO2001038326A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038324A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 05/31/2001 | WO2001038323A1 Pyrazinone thrombin inhibitors |
| 05/31/2001 | WO2001038322A1 Inhibitors of histone deacetylase |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038318A1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/31/2001 | WO2001038316A2 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands |
| 05/31/2001 | WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038310A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 05/31/2001 | WO2001038309A1 β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |